首页> 美国卫生研究院文献>Clinical and Experimental Immunology >Soluble IL-2 receptor and tumour necrosis factor-alpha in plasma of haemophilia patients infected with HIV.
【2h】

Soluble IL-2 receptor and tumour necrosis factor-alpha in plasma of haemophilia patients infected with HIV.

机译:感染HIV的血友病患者血浆中的可溶性IL-2受体和肿瘤坏死因子-α。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We measured plasma concentrations of soluble receptors for IL-2 (sIL-2R) and tumour necrosis factor-alpha (TNF-alpha) in 149 haemophilia patients. Soluble IL-2R levels were elevated in 37% of 62 HIV-seronegative patients (mean 570 +/- 27 U/ml versus 361 +/- 17 U/ml in the control group, P less than 0.0001), in 78% of 68 HIV-seropositive patients (928 +/- 49 U/ml, P less than 0.0001), and in 95% of 19 AIDS/ARC patients (1578 +/- 199 U/ml, P less than 0.0001 compared with controls and with HIV-seronegative patients; P less than 0.005 compared with HIV-seropositive asymptomatic patients). A negative correlation was observed between sIL-2R, relative and absolute numbers of CD4+ cells (P less than 0.0001), and CD4/CD8 ratios (P less than 0.0001). There was also a negative correlation between sIL-2R in plasma and the cellular expression of IL-2R (P less than 0.001). We found a significant association of sIL-2R and plasma neopterin (P less than 0.0001). With progression of the disease from HIV-seronegative to seropositive without symptoms and to full manifestation of AIDS/ARC, sIL-2R plasma levels increased. The highest levels were found at the time of diagnosis of AIDS/ARC, but the levels decreased again during the following 18 months. Eight per cent of HIV-seronegative patients, 32% of HIV-seropositive patients, and 24% of patients with AIDS/ARC had increased plasma TNF-alpha. We conclude that sIL-2R and TNF-alpha plasma levels are elevated in HIV-infected haemophilia patients and that sIL-2R is a marker for disease progression from asymptomatic HIV-seropositive to AIDS/ARC.
机译:我们测量了149名血友病患者中IL-2(sIL-2R)和肿瘤坏死因子-α(TNF-alpha)可溶性受体的血浆浓度。在62例HIV阴性患者中,有37%的可溶性IL-2R水平升高(平均570 +/- 27 U / ml,而对照组为361 +/- 17 U / ml,P小于0.0001),在78%的患者中与对照组和对照组相比,有68例HIV血清阳性患者(928 +/- 49 U / ml,P小于0.0001),在19名AIDS / ARC患者中,有95%(1578 +/- 199 U / ml,P小于0.0001) HIV血清反应阴性的患者;与HIV血清反应阳性的无症状患者相比,P小于0.005)。 sIL-2R,CD4 +细胞的相对和绝对数量(P小于0.0001)和CD4 / CD8比值(P小于0.0001)之间存在负相关。血浆中的sIL-2R与IL-2R的细胞表达之间也呈负相关(P小于0.001)。我们发现sIL-2R与血浆新蝶呤之间存在显着关联(P小于0.0001)。随着疾病的发展,从HIV阴性转为血清阳性,无任何症状并完全表现为AIDS / ARC,sIL-2R血浆水平升高。在诊断AIDS / ARC时发现最高水平,但在随后的18个月中该水平再次下降。 8%的HIV血清阴性患者,32%的HIV血清阳性患者和24%的AIDS / ARC患者血浆TNF-α升高。我们得出的结论是,在HIV感染的血友病患者中sIL-2R和TNF-α血浆水平升高,并且sIL-2R是疾病从无症状HIV血清阳性转为AIDS / ARC的标志。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号